Open AccessElderly diabetic patient with surgical site mucormycosis extending to bowel
Author(s) -
Atul Patel,
Himanshu J. Vora,
Ketan Patel,
Bhavin Patel
Publication year - 2010
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.62877
Subject(s) - mucormycosis , medicine , immunosuppression , surgical debridement , debridement (dental) , surgery , amphotericin b , intensive care medicine , antifungal , dermatology
Mucormycosis is rare in clinical practice. Most infections are acquired by inhalation; other portals of entry are traumatic implantation and ingestion in immunocompromised host. Mucormycosis is life threatening infection in immunocompromised host with variable moratlity ranging from 15-81% depending upon site of infection. General treatment principles include early diagnosis, correction of underlying immunosuppression and metabolic disturbances, adequate surgical debridement along with amphotericin therapy. We describe surgical site mucormycosis extended to involve large bowel in elderly diabetic patient.